99 related articles for article (PubMed ID: 9380016)
21. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
22. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A
J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297
[TBL] [Abstract][Full Text] [Related]
23. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
Ivkovic B; Bakthavachalam V; Zhang W; Parini A; Diz D; Bosch S; Neumeyer JL; Lanier SM
Mol Pharmacol; 1994 Jul; 46(1):15-23. PubMed ID: 8058049
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of imidazoline I2 binding sites in pig brain.
Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
[TBL] [Abstract][Full Text] [Related]
25. In vivo estimation of imidazoline(2) binding site turnover.
Paterson LM; Robinson ES; Nutt DJ; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():367-70. PubMed ID: 15028614
[TBL] [Abstract][Full Text] [Related]
26. Targeting imidazoline site on monoamine oxidase B through molecular docking simulations.
Moraes FP; de Azevedo WF
J Mol Model; 2012 Aug; 18(8):3877-86. PubMed ID: 22426510
[TBL] [Abstract][Full Text] [Related]
27. Differences in the structure of A and B forms of human monoamine oxidase.
Cawthon RM; Pintar JE; Haseltine FP; Breakefield XO
J Neurochem; 1981 Aug; 37(2):363-72. PubMed ID: 7264664
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
29. Computational comparison of imidazoline association with the I2 binding site in human monoamine oxidases.
Basile L; Pappalardo M; Guccione S; Milardi D; Ramsay RR
J Chem Inf Model; 2014 Apr; 54(4):1200-7. PubMed ID: 24601544
[TBL] [Abstract][Full Text] [Related]
30. Iododerivative of pargyline: a potential tracer for the exploration of monoamine oxidase sites by SPECT.
Lena I; Ombetta JE; Chalon S; Dognon AM; Baulieu JL; Frangin Y; Garreau L; Besnard JC; Guilloteau D
Nucl Med Biol; 1995 Aug; 22(6):727-36. PubMed ID: 8535333
[TBL] [Abstract][Full Text] [Related]
31. Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.
MacInnes N; Handley SL
Eur J Pharmacol; 2005 Jun; 516(2):139-44. PubMed ID: 15925361
[TBL] [Abstract][Full Text] [Related]
32. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio).
Setini A; Pierucci F; Senatori O; Nicotra A
Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):153-61. PubMed ID: 15621520
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
Cesura AM; Bös M; Galva MD; Imhof R; Da Prada M
Mol Pharmacol; 1990 Mar; 37(3):358-66. PubMed ID: 2314388
[TBL] [Abstract][Full Text] [Related]
35. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A.
Jones TZ; Giurato L; Guccione S; Ramsay RR
FEBS J; 2007 Mar; 274(6):1567-75. PubMed ID: 17480205
[TBL] [Abstract][Full Text] [Related]
36. Differences in the structures of monoamine oxidases A and B in rat clonal cell lines.
Cawthon RM; Breakefield XO
Biochem Pharmacol; 1983 Feb; 32(3):441-8. PubMed ID: 6847697
[TBL] [Abstract][Full Text] [Related]
37. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
38. Use of high affinity, radioiodinated probes for identification of imidazoline/guanidinium receptive sites.
Lanier SM; Lanier B; Bakthavachalam V; McGrath CR; Neumeyer JL
Ann N Y Acad Sci; 1995 Jul; 763():106-11. PubMed ID: 7677319
[TBL] [Abstract][Full Text] [Related]
39. Rat monoamine oxidase B expressed in Escherichia coli has a covalently-bound FAD.
Hirashiki I; Ogata F; Ito A
Biochem Mol Biol Int; 1995 Sep; 37(1):39-44. PubMed ID: 8653086
[TBL] [Abstract][Full Text] [Related]
40. Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody.
Denney RM; Fritz RR; Patel NT; Abell CW
Science; 1982 Mar; 215(4538):1400-3. PubMed ID: 7063850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
